Measuring quality of life: Impact of chemotherapy for advanced colorectal cancer. Experience from two recent large phase III trials

British Journal of Cancer

Volumn 77, Issue SUPPL. 2, 1998, Pages 9-14

  Anderson, H ^a   Palmer, M K ^b  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Advanced colorectal cancer; Chemotherapy; EORTC core instrument; EuroQol; Quality of life; Raltitrexed; Rotterdam symptom checklist

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; RALTITREXED;

ALOPECIA; BLOOD TOXICITY; CLINICAL TRIAL; COLORECTAL CANCER; CONFERENCE PAPER; DIARRHEA; FATIGUE; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; MULTICENTER STUDY; NAUSEA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RASH; SYMPTOM; TREATMENT OUTCOME; VOMITING;

ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; ENZYME INHIBITORS; FLUOROURACIL; HUMANS; LEUCOVORIN; QUALITY OF LIFE; QUESTIONNAIRES; QUINAZOLINES; THIOPHENES; THYMIDYLATE SYNTHASE;

EID: 0031935917     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.420     Document Type: Article

References (19)

1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner II, Fleishman SB and de Haes JC (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85: 365-376
2. Allen-Mersh TG, Earlam S, Fordy C, Abrams K and Houghton J (1994) Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 344: 1255-1260
3. Batel-Copel LM, Kornblith AB, Batel PC and Holland JC (1997) Do oncologists have an increasing interest in the quality of life of their patients? A literature review of the last 15 years. Eur J Cancer 33: 29-32
4. Bremnes RM, Andersen K and Wist EA (1995) Cancer patients, doctors and nurses vary in their willingness to undertake cancer chemotherapy. Eur J Cancer 31A: 1955-1959
5. Cunningham D, Zalcberg JR, Rath U, Oliver I, van Cutsem E, Svensson C, Seitz JF, Harper P, Kerr D, Perez-Manger G and the Tomudex Colorectal Cancer Study Group (1996) Final results of a randomised trial comparing 'Tomudex'® (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. Am Oncol 7: 961-965
6. De Haes JCJM, Pruyn JFA and van Knippenberg FCE (1983) Klachtenlijst voor kankerpatiënten, eerste ervaringen. Nederlands Tijdschrift voor Geneeskunde 38: 403-422
7. De Haes JCJM, van Knippenberg FCE and Neijt JP (1990) Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 62: 1034-1038
8. Fayers PM, Hopwood P, Harvey A, Girling DJ, Machin D and Stephens R (1997) Quality of life assessment in clinical trials -guidelines and a checklist for protocol writers: the UK Medical Research Council experience. Eur J Cancer 33: 20-28
9. Glimelius B, Hoffman K, Graf W, Påhlman L and Sjödén PO (1994) Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. Cancer 73: 556-562
10. Gower NH, Rudd RM, Ruiz de Elvira MC, Spiro SG, James LE, Harper PG and Souhami RL (1995) Assessment 'quality of life' using a daily diary card in a randomised trial of chemotherapy in small-cell lung cancer. Ann Oncol 6: 575-580
11. Harper P, on behalf of the 'Tomudex' Study Group (1997) Advanced colorectal cancer (ACC): results from the latest Tomudex® (raltitrexed) comparative study (abstract 802). Proc Am Soc Clin Oncol 16: 228a
12. International Working Group in Colorectal Cancer (1997) An international, multidisciplinary approach to the management of advanced colorectal cancer. Eur J Surg Oncol 23 (suppl. A): 4-66
13. Kerr DJ (1997) Clinical efficacy of 'Tomudex' (raltitrexed) in advanced colorectal cancer. Anti-Cancer Drugs 8 (suppl. 2): S11-S15
14. Nayfield SG, Ganz PA, Moinpour CM, Cella DF and Hailey BJ (1992) Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials. Qual Life Res 1: 203-210
15. Nordic Gastrointestinal Tumor Adjuvant Therapy Group (1992) Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. J Clin Oncol 10: 904-911
16. Scheithauer W, Rosen H, Kornek G-V, Sebesta C, Depisch D (1993) Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. Br Med J 306: 752-755
17. Slevin ML, Stubbs L, Plant HJ, Wilson P, Gregory WM, Armes PJ and Downer SM (1990) Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. Br Med J 300: 1458-1460
18. Taylor KM, Feldstein ML, Skeel RT, Pandya KJ, Ng P and Carbone PP (1994) Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group Investigators. J Clin Oncol 12: 1796-1805
19. Williams A (1990) EuroQol - a new facility for the measurement of health related quality of life. The EuroQol group. Health Policy 16: 199-208